Loading...

Genertec Universal Medical Group Company Limited

UMTAF•PNK
Financial Services
Financial - Credit Services
$0.59
$0.04(8.18%)

Genertec Universal Medical Group Company Limited (UMTAF) Stock Overview

Explore Genertec Universal Medical Group Company Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap1.1B
P/E Ratio4.14
EPS (TTM)$0.13
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.33

UMTAF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Genertec Universal Medical Group Company Limited (UMTAF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.33.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 4.14 and a market capitalization of 1.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;